Articles with keyword ovarian cancer

Intraperitoneal chemotherapy in patients with advanced ovarian cancer: phase 2 institutional study (A.S. Tyulyandina, V.М. Nechushkina, L.V. Cherkes, K.Y. Morkhov, A.A. Rumyantsev, I.A. Pokataev, E.V. Glazkova, E.R. Virshke, D.Y. Frantsev, K.I. Zhordania, Y.V. Bujdenok, R.K. Valiev, A.V. Petrovsky, Y.S. Sergeev, I.V. Panichenko, A.A. Bulanov, M.B. Stenina, S.A. Tyulyandin)

ovarian cancer, intraperitoneal chemotherapy, intravenous chemotherapy, optimal cytoreduction, cisplatin, paclitaxel.

First line dosointensive chemotherapy for Disseminated ovarian cancer after non optimal Cyted reduction: Results of the phase ii study (A.A. Rumyantsev, A.S. Tyulyandina, I.A. Pokataev, K.Yu. Morkhov, V.M. Nechushkina, V.E. Nikulin, S.O. Nikogosyan, K.I. Zhordania, S.A. Tyulyandin)

ovarian cancer, dose-dense chemotherapy, dose-intensive chemotherapy, suboptimal debulking, non-optimal debulking.

Debulking surgery in oncogynecology (S.Ya. Maximov, I.V. Sobolev, A.S. Hadjimba, A.A. Ilin, E.D. Gershfeld, D.-K. Reyes Santiago)

cytoreductive, debulking surgery, ovarian cancer, cervical cancer, endometrial cancer, chemotherapy, radiotherapy

GYNAECOLOGICAL CANCER IN PATIENTS OF REPRODUCTIVE AGE (S.Ya. Maximov, A.S. Khadzhimba, A.A. Ilin I.V. Sobolev, E.A. Vishinskaya)

ovarian cancer, endometrial cancer, cervical cancer, reproductive age, morbidity, mortality, treatment